Glasgow brings together scientists and clinicians to promote and develop the best in cancer research, drug discovery and patient care. We are ranked among the top 50 universities* in the world for medicine and health.
We work together to:
- identify the molecular changes that cause cancer
- develop drugs targeted to these changes; and
- bring new therapies through preclinical and clinical trials.
We are a major component of the Cancer Research UK West of Scotland Cancer Centre, and we unite:
- the Beatson Institute for Cancer Research
- the Translational Research Centre
- the Paul O’Gorman Leukaemia Research Centre at the University of Glasgow
- the CRUK clinical trials unit (CTU).
Our research expertise
We take an integrated approach. Ranging across chemistry, basic biological science, veterinary pathology and cancer medicine, we work to break down barriers. The result is an outstanding environment in which we train the next generation of scientific and clinical cancer researcher leaders.
Our areas of expertise include:
- structure led drug discovery
- studies of cell growth, motility and survival
- state-of-the-art proteomics/metabolomics
- state-of-the-art (epi)genetics/transcriptomics
- a strong human/mouse pathology programme; and
- the analysis of complex genetic animal models including the development of sophisticated pre-clinical trials.
Our focus on colorectal, pancreatic and haematological cancers incorporates a highly active clinical trials programme.
Our clinical trials unit is a vital coordinator of clinical studies. It works to:
- bring together phase 1-3 trails across the range of common solid and haematological cancers; and
- ensure a direct connection between our basic science and the cancer patient.
*Times Higher Education World University Subject Rankings: clinical, pre-clinical and health.